Cancer Stem Cells: Impact on Treatment - 2018

Overview

Second Conference Cancer Stem Cells (CSCs): Impact on Treatment - 2018 will be devoted to the problem of primary and acquired therapy resistance associated with disease progression and poor clinical outcome in cancer patients. It is planned that pre-clinical and clinical sessions will be included into the program of the conference. The leading basic researchers and clinicians will be invited to provide educational lectures and to serve as chairs of the Symposium Sessions.

This Conference will highlight 

• signaling pathways contributing to the treatment resistance and disease progression;
• role of CSCs in the treatment failure;
• molecular mechanisms associated with CSC aggressiveness and increased metastatic potential;
• CSC metabolism;
• circadian rhythms in CSCs and metronomic chemotherapy;
• crosstalk between CSCs and microenvironmental factors (tumor stroma, immune system);
• biological, biochemical, pathological methods allowing CSC identification within the malignant tumors;
• development of novel biomarkers and therapeutic targets to predict and overcome therapy resistance associated with CSC activities;
• novel therapeutic approaches to combat locally advanced, metastatic or relapsed malignant diseases;
• chemical agents against CSCs;
• translational oncology: how to make bridge between basic researchers and clinicians;
• clinical trials based on pre-clinical findings